Krsnaa Diagnostics Limited

NSE KRSNAA.NS

Krsnaa Diagnostics Limited Debt to Equity Ratio for the year ending March 31, 2024: 0.20

Krsnaa Diagnostics Limited Debt to Equity Ratio is 0.20 for the year ending March 31, 2024, a 348.77% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Krsnaa Diagnostics Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.04, a -15.96% change year over year.
  • Krsnaa Diagnostics Limited Debt to Equity Ratio for the year ending March 31, 2022 was 0.05, a -94.77% change year over year.
  • Krsnaa Diagnostics Limited Debt to Equity Ratio for the year ending March 31, 2021 was 1.00, a 184.80% change year over year.
  • Krsnaa Diagnostics Limited Debt to Equity Ratio for the year ending March 31, 2020 was -1.18, a 40.87% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
NSE: KRSNAA.NS

Krsnaa Diagnostics Limited

CEO Mr. Mitesh Dave
IPO Date Aug. 16, 2021
Location India
Headquarters S.No.243,A-Hissa No.6/6
Employees 3,700
Sector Health Care
Industries
Description

Krsnaa Diagnostics Limited provides diagnostic services. The company offers a range of technology-enabled diagnostic services, such as radiology, pathology/clinical laboratory, and tele-radiology services to public and private hospitals, medical colleges, and community health centers. As of December 31, 2020, it operated 1,801 diagnostic centers in 13 states across India. The company was incorporated in 2010 and is based in Pune, India.

Similar companies

WINDLAS.NS

Windlas Biotech Limited

USD 11.38

6.02%

VIJAYA.NS

Vijaya Diagnostic Centre Limited

USD 13.39

-3.61%

DEVYANI.NS

Devyani International Limited

USD 2.06

0.53%

KIMS.NS

Krishna Institute of Medical Sciences Limited

USD 7.15

0.36%

CARTRADE.NS

CarTrade Tech Limited

USD 16.32

-0.28%

StockViz Staff

January 16, 2025

Any question? Send us an email